See the latest news and media coverage for EQL Pharma. We track all announcements, press releases, and industry mentions in real time, all in one place.
Swedish generic and specialty pharmaceutical developer and marketer
eqlpharma.comLast updated
In short: EQL Pharma reported record sales but faced margin pressure from inventory write-downs while continuing its international expansion.
The board is re-elected with the addition of Niraj Kumar, Deloitte is appointed as auditor and up to 100,000 subscription options are granted to management.
Sales unchanged at 106.9 MSEK, gross margin fell to 17% after write-downs of 20 MSEK. Two products were launched, new CSCO appointed.
He takes office in October 2026 and replaces Martin Kristofferson who has been interim manager.
The annual report is available on the website and contains financial information for the fiscal year.
Despite a flat quarter and a SEK 20 million inventory write-down, EQL Pharma AB (FRA:7JK) reaffirms its full-year guidance, citing improved stock availability and a...
Results continue to plummet for EQL Pharma, where Cellavision founder Christer Fåhraeus is a major shareholder. "The tough period had a beginning and will..."
DNB Carnegie has revised downward its EBIT (operating profit) forecasts for the generics specialist EQL Pharma by 3 to 8%, and...
An employee at the pharmaceutical company EQL Pharma is suspected of insider trading, confirms the company's CEO Axel Schörling to Di. A former employee is also suspected.
Track EQL Pharma and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.
Browse news for competitors to EQL Pharma and other trending companies.